NCT01947764

Brief Summary

In the resource-limited settings where most HIV-infected children live, neither the most effective strategies to inform children of their HIV status, nor the impact of disclosure is well understood. This team's long-term goal is to provide evidence to improve the chronic disease management of HIV-infected children in resource-limited settings. The purpose of this study is to assess the effect of a patient-centered intervention guiding disclosure to HIV-infected Kenyan children using a randomized trial comparing the intervention to routine care. The primary endpoint will be probability of disclosure among children, with secondary endpoints of adherence, clinical outcomes, psychological distress and social outcomes. This work will be done within the Academic Model Providing Access to Healthcare (AMPATH) which currently cares for almost 120,000 adult and pediatric HIV-infected patients in 25 clinics in Kenya. We will utilize the excellent infrastructure of this academic partnership to provide the first comprehensive assessment of the physical, psychological, and social impact of disclosure for HIV-infected children in East Africa. We will evaluate the impact of an intensive disclosure intervention by pursuing these specific aims: Aim 1: Expand and modify an existing pediatric HIV disclosure intervention used in Kenya to include patient-centered components; Aim 2: Perform a randomized trial to compare the impact of clinic implementation of the culturally adapted, pediatric disclosure intervention on the prevalence of disclosure and on the medical, psychological, and social outcomes for HIV-infected Kenyan children ages 10-15 years compared to children exposed to standard clinical care. The usual care control arm will have disclosure training for all clinicians, disclosure chart materials, and an existing protocol to implement disclosure for patients over 10 years. The disclosure intervention will consist of patient-centered materials to guide disclosure, including videotaped narratives; disclosure counselors; post-disclosure child support groups; and the usual care resources. The central hypothesis is that an intensive disclosure intervention based on culture-specific qualitative work and a patient-centered approach will allow for disclosure in which more children know their HIV status at younger ages, and they also have improved medication adherence, improved medical outcomes, unimpaired psychological outcomes, and no increase in experienced stigma over time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
330

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
Completed

Started Aug 2012

Typical duration for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

September 18, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 20, 2013

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

March 8, 2017

Status Verified

March 1, 2017

Enrollment Period

3.8 years

First QC Date

September 18, 2013

Last Update Submit

March 6, 2017

Conditions

Keywords

HIVDisclosurePediatrics

Outcome Measures

Primary Outcomes (1)

  • Disclosure Status

    Percent of children (ages 10-15) documented as knowing their HIV status; Percent knowing why they take medicines; Percent knowing why they attend AMPATH clinic

    2 years

Study Arms (2)

Usual Care

NO INTERVENTION

The Usual Care components for the control clinics will include the following: * All clinicians (pediatricians, medical officers, clinical officers, and nurses) caring for children undergo the existing 3-day disclosure training * Chart materials to guide and document disclosure counseling and visits * The presence of the AMPATH SOP mandating disclosure to children ages 10 and older. In Usual Care clinics, no specific personnel will be dedicated to disclosure.

HADITHI Intervention

EXPERIMENTAL

In addition to the Usual Care components, the HADITHI Intervention clinics will include: * Modified materials to guide disclosure sessions * Videotaped narratives for parental counseling * Dedicated disclosure counselors to initiate and conduct the disclosure process * Post-disclosure support groups for children The disclosure counselors will avail themselves for conducting disclosure with any families referred to them by the AMPATH clinicians. They will post fliers that describe their services for parents and caregivers so that families can self-refer for disclosure counseling. Similarly, the post-disclosure support groups for children will be available for anyone enrolled in the clinic and families will be able to self-refer or to be referred by the clinicians.

Behavioral: HADITHI Intervention

Interventions

The HADITHI Intervention consists of a culturally adapted, multi-component clinic-based intervention designed to support families in pediatric HIV disclosure in Kenya. In addition to the Usual Care components, the HADITHI Intervention clinics will have the following intervention components: Culturally modified curricula materials, including videotaped narratives, to guide counseling and group sessions. Dedicated disclosure counselors to initiate and conduct disclosure, with one-on-one counseling for caregivers and children, as well as family-based sessions. Post-disclosure peer support groups, facilitated by the disclosure counselors, for children who have gone through disclosure.

HADITHI Intervention

Eligibility Criteria

Age10 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • HIV-infected (documented by DNA-PCR \[Amplicor, Roche, Basel, Switzerland\] for children younger than 18 months and by 2 parallel HIV rapid ELISA tests using Determine and Bioline for children older than 18 months), AND
  • Child age 10 to 15 years, AND
  • Child is currently enrolled or newly enrolled in HIV care at one of the following AMPATH HIV clinics: Moi Teaching and Referral Hospital (Eldoret), Chulaimbo, Kitale, Mosoriot, Turbo, Webuye, Burnt Forest, or Khuyangu.

You may not qualify if:

  • Mental or physical incapacity of legal caregiver leading to inability to provide informed consent.
  • Mental or physical incapacity of the child leading to inability to answer the evaluation questions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moi Teaching and Referral Hospital - AMPATH Center

Eldoret, 30100, Kenya

Location

Study Officials

  • Rachel C Vreeman, MD, MS

    Indiana University

    PRINCIPAL INVESTIGATOR
  • Winstone Nyandiko, MBChB, MPH

    Moi University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Pediatrics

Study Record Dates

First Submitted

September 18, 2013

First Posted

September 20, 2013

Study Start

August 1, 2012

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

March 8, 2017

Record last verified: 2017-03

Locations